Clinical trialNCT02283294CompletedPhase 3Interventional

Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation

SponsorUniversity of South FloridaEnrollment91Atrial FibrillationStrokeTransient Ischemic Attack

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate if Apixaban will decrease the complication of having another stroke for people who have atrial fibrillation if initiated earlier than standard of care.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Michael Fradley, M.D.
University of South Florida, Department of Cardiovascular Sciences
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Los Angeles Biomedical Research Institute at Harbor-Ucla Medical Center
Torrance, California, United States
Bayfront Health St Petersburg
St. Petersburg, Florida, United States
Tampa General Hospital
Tampa, Florida, United States
University of South Florida
Tampa, Florida, United States
University of Louisville
Louisville, Kentucky, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Apixaban →Warfarin →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Apr 2015
Primary completion: 30 Jun 2019
Completion: 30 Jun 2019
Last update posted: 30 Nov 2021
Registered enrollment: 91
Registry id: NCT02283294

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.